Myriad Genetics, Inc. (MYGN)
Total Valuation
MYGN has a market cap or net worth of $1.94 billion. The enterprise value is $1.95 billion.
Market Cap | 1.94B |
Enterprise Value | 1.95B |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, after market close.
Earnings Date | May 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MYGN has 89.87 million shares outstanding. The number of shares has increased by 2.73% in one year.
Shares Outstanding | 89.87M |
Shares Change (YoY) | +2.73% |
Shares Change (QoQ) | +5.49% |
Owned by Insiders (%) | 2.40% |
Owned by Institutions (%) | 103.06% |
Float | 74.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 728.80 |
PS Ratio | 2.58 |
Forward PS | 2.30 |
PB Ratio | 2.48 |
P/FCF Ratio | n/a |
PEG Ratio | 1.40 |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.59 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.19.
Current Ratio | 2.01 |
Quick Ratio | 1.64 |
Debt / Equity | 0.19 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -89.41 |
Financial Efficiency
Return on equity (ROE) is -34.70% and return on invested capital (ROIC) is -27.52%.
Return on Equity (ROE) | -34.70% |
Return on Assets (ROA) | -22.60% |
Return on Capital (ROIC) | -27.52% |
Revenue Per Employee | $278,963 |
Profits Per Employee | -$97,519 |
Employee Count | 2,700 |
Asset Turnover | 0.65 |
Inventory Turnover | 11.22 |
Taxes
In the past 12 months, MYGN has paid $1.10 million in taxes.
Income Tax | 1.10M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.53% in the last 52 weeks. The beta is 1.96, so MYGN's price volatility has been higher than the market average.
Beta (1Y) | 1.96 |
52-Week Price Change | -6.53% |
50-Day Moving Average | 22.08 |
200-Day Moving Average | 19.50 |
Relative Strength Index (RSI) | 43.74 |
Average Volume (30 Days) | 645,888 |
Short Selling Information
The latest short interest is 4.80 million, so 5.34% of the outstanding shares have been sold short.
Short Interest | 4.80M |
Short Previous Month | 4.00M |
Short % of Shares Out | 5.34% |
Short % of Float | 6.44% |
Short Ratio (days to cover) | 6.66 |
Income Statement
In the last 12 months, MYGN had revenue of $753.20 million and -$263.30 million in losses. Loss per share was -$3.18.
Revenue | 753.20M |
Gross Profit | 517.00M |
Operating Income | -257.40M |
Pretax Income | -262.20M |
Net Income | -263.30M |
EBITDA | -186.10M |
EBIT | -259.30M |
Loss Per Share | -$3.18 |
Balance Sheet
The company has $140.90 million in cash and $152.10 million in debt, giving a net cash position of -$11.20 million or -$0.12 per share.
Cash & Cash Equivalents | 140.90M |
Total Debt | 152.10M |
Net Cash | -11.20M |
Net Cash Per Share | -$0.12 |
Equity / Book Value | 783.20M |
Book Value Per Share | 8.71 |
Working Capital | 157.70M |
Cash Flow
In the last 12 months, operating cash flow was -$110.90 million and capital expenditures -$73.30 million, giving a free cash flow of -$184.20 million.
Operating Cash Flow | -110.90M |
Capital Expenditures | -73.30M |
Free Cash Flow | -184.20M |
FCF Per Share | -$2.23 |
Margins
Gross margin is 68.64%, with operating and profit margins of -34.17% and -34.96%.
Gross Margin | 68.64% |
Operating Margin | -34.17% |
Pretax Margin | -34.81% |
Profit Margin | -34.96% |
EBITDA Margin | -24.71% |
EBIT Margin | -34.43% |
FCF Margin | -24.46% |
Dividends & Yields
MYGN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -2.73% |
Shareholder Yield | -2.73% |
Earnings Yield | -13.57% |
FCF Yield | -9.49% |
Analyst Forecast
The average price target for MYGN is $22.50, which is 5.54% higher than the current price. The consensus rating is "Buy".
Price Target | $22.50 |
Price Target Difference | 5.54% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 9.35% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 26, 2009. It was a forward split with a ratio of 2:1.
Last Split Date | Mar 26, 2009 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
MYGN has an Altman Z-Score of 2.51 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.51 |
Piotroski F-Score | 3 |